Cheryl Hobbs

Cheryl Hobbs currently serves as the Director of Genetic Toxicology at Inotiv since January 2022. Prior to this role, Cheryl held several positions at Integrated Laboratory Systems, Inc. (ILS) from 2006, including Director of Toxicology, Program Manager in Toxicology and Genetic Toxicology, and Research Scientist. Cheryl's early career includes an Assistant Investigator role at Lankenau Hospital and various positions at the Lankenau Institute for Medical Research, where Cheryl worked as a Scientist and Research Associate. Cheryl's experience also encompasses significant roles at Sterling Winthrop Pharmaceuticals Research Division and Fox Chase Cancer Center. Cheryl earned both a Master’s and a Ph.D. in Bioscience and Biotechnology from Drexel University and a Bachelor’s degree in Biological Science and Computer Science from the University of Delaware.